From Aquarium-to-Bedside
Using a zebrafish model developed in the laboratory of Professor Scott C. Baraban, Epygenix Therapeutics is poised to commercialize epilepsy drugs discovered in zebrafish.
UCSF Technology Sings at San Francisco Opera
In a strange marriage of arts and science, The San Francisco Opera costume department teamed up with doctors from UCSF to create a mask that will allow the company's singers to safely rehearse together.
Alliance to Advance Neuroscience Research
UCSF's Weill Neurohub Joins Forces with UC Berkeley, Genentech and Roche to Advance Neuroscience Research
New Alliance to Fight Autoimmune Diseases
UCSF Partners With Eli Lilly to Better Understand Underlying Drivers of Autoimmunity and Accelerate the Development of Better Therapies.
UCSF and BridgeBio to Develop New Therapies
BridgeBio is building close relationships with UCSF investigators to bring potential therapies into the clinic quickly.
Autobahn Collaboration to Accelerate UCSF Innovation
UCSF's Strategic Alliances team launched a new collaboration with Autobahn Labs, to help move novel therapeutics more quickly to market.
An Interview: Leadership in a  Post Pandemic Landscape
"We're not here to turn researchers into entrepreneurs – we are here to let the researcher understand what it is, and then participate however they like."
UCSF Startup and Bio-Me to Collaborate
UCSF startup Siolta Therapeutics, founded by Professor Susan Lynch, and Bio-Me aim to develop a predictive test for infants to determine microbiome-based pediatric allergies.
Gilead to Acquire a Nearly 50% Interest in UCSF Startup
Gilead Sciences set to acquire a 49.9% equity interest in Max Krummel's Pionyr Immunotherapeutics for $275 Million.

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...